Pakistan faces a significant health crisis, with over 100 million adults classified as overweight or obese, prompting warnings from health experts at a recent event in Karachi. They emphasized that obesity leads to serious conditions like diabetes, hypertension, and heart disease, and must be urgently addressed.

Prof. Waseem Hanif highlighted that South Asians are at higher risk for obesity-related issues, suggesting that the ideal BMI for this population should be around 23. He introduced tirzepatide, a groundbreaking treatment that can reduce body weight by up to 25% when combined with lifestyle changes.

Dr. Riasat Ali Khan pointed out that non-communicable diseases are on the rise, linking them directly to obesity. He emphasized that managing obesity can significantly lower the burden of related health issues.

Dr. Khurram Hussain from Getz Pharma expressed commitment to providing accessible treatments for obesity and its complications. At the same time, Dr. Khurram Nasir shared alarming findings from the PAK-SEHAT study, revealing that nearly three out of four adults in Pakistan are obese.

The event was a positive step towards launching Pakistan’s first generic tirzepatide, welcomed by numerous healthcare professionals.